RNR is tightly regulated because imbalances in dNTP pools can lead to genomic instability, a hallmark of cancer. Cancer cells, characterized by rapid and uncontrolled division, have increased demands for DNA synthesis. Consequently, they often exhibit elevated levels of RNR activity. This makes RNR not only a marker for proliferating cells but also a potential therapeutic target in cancer treatment.
